NYSE: PATHUipath Inc Stock
$10.87+0.40 (+3.82%)
Updated Apr 23, 2025
PATH Price
$10.87
Fair Value Price
N/A
Market Cap
$5.99B
52 Week Low
$9.38
52 Week High
$20.95
P/E
-83.62x
P/B
3.25x
P/S
5.57x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.43B
Earnings
-$73.69M
Gross Margin
82.7%
Operating Margin
-5.46%
Profit Margin
-5.2%
Debt to Equity
0.55
Operating Cash Flow
$321M
Beta
1.91
Next Earnings
Jun 20, 2025
Ex-Dividend
N/A
Next Dividend
N/A
PATH Overview
UiPath Inc. offers an end-to-end platform customers use to build, manage, run, engage, measure, and govern automations across departments within an organization. The platform enables software robots (Robotic Process Automation) to perform an array of actions (logging into applications, extracting information from documents, moving folders, filling in forms, and updating information fields and databases). The company's platform interacts with and automates processes across a company's existing enterprise stack. UiPath was founded in 2005 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PATH's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Software Infrastructure
Industry Rating
A
PATH
Ranked#19 of 123
Ranked#19 of 123
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.51 | A | |
| $59.09 | A | |
| $5.16 | A |
Be the first to know about important PATH news, forecast changes, insider trades & much more!
PATH News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PATH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PATH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PATH is good value based on its book value relative to its share price (3.25x), compared to the US Software - Infrastructure industry average (9.76x)
P/B vs Industry Valuation
PATH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more PATH due diligence checks available for Premium users.
Valuation
PATH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-83.62x
Industry
-64.87x
Market
26.95x
PATH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.25x
Industry
9.76x
PATH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PATH's financial health
Profit margin
Revenue
$423.6M
Net Income
$51.8M
Profit Margin
12.2%
PATH's Earnings (EBIT) of -$78.10M... subscribe to Premium to read more.
Interest Coverage Financials
PATH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.9B
Liabilities
$1.0B
Debt to equity
0.55
PATH's short-term assets ($2.34B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PATH's short-term assets ($2.34B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PATH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PATH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$146.1M
Investing
-$16.7M
Financing
-$17.0M
PATH's operating cash flow ($320.57M)... subscribe to Premium to read more.
Debt Coverage Financials
PATH vs Software Infrastructure Stocks
Uipath Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.